Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

Rheumatology
D van der HeijdeAtul Deodhar

Abstract

The aim was to assess the long-term safety and efficacy of certolizumab pegol over 4 years of continuous treatment in patients with axial spondyloarthritis (axSpA), including both AS and non-radiographic (nr-) axSpA. RAPID-axSpA was a phase 3 randomized trial, double blind and placebo controlled to week 24, dose blind to week 48 and open label to week 204. Patients had a clinical diagnosis of axSpA, meeting Assessment of SpondyloArthritis international Society (ASAS) criteria, and had active disease. The assessed outcomes included ASAS20, ASAS40, AS DAS (ASDAS), BASDAI, BASFI and BASMI scores, along with selected measures of remission. Further patient-reported outcomes, peripheral arthritis, enthesitis, uveitis and quality-of-life measures are also reported. Two hundred and eighteen of 325 patients randomized (AS: 121; nr-axSpA: 97) received certolizumab pegol from week 0. Of these, 65% remained in the study at week 204 (AS: 67%; nr-axSpA: 63%). Across all outcomes, for AS and nr-axSpA, sustained improvements were observed to week 204 [week 204 overall axSpA: ASAS20: 54.1% (non-responder imputation); 83.7% (observed case, OC); ASAS40: 44.0% (non-responder imputation); 68.1% (OC); ASDAS inactive disease: 32.1% (last observation ...Continue Reading

References

Dec 14, 2002·Annals of the Rheumatic Diseases·L C DowardM A Chamberlain
Nov 13, 2003·Arthritis and Rheumatism·John C DavisUNKNOWN Enbrel Ankylosing Spondylitis Study Group
Feb 5, 2005·Arthritis and Rheumatism·Désirée van der HeijdeUNKNOWN Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
Apr 17, 2009·The Journal of Rheumatology·Jasvinder A Singh, Vibeke Strand
Jun 13, 2015·Current Rheumatology Reports·Robert Landewé, Astrid van Tubergen

❮ Previous
Next ❯

Citations

Apr 24, 2018·Expert Opinion on Biological Therapy·Alexis JonesPedro M Machado
Jul 12, 2017·British Journal of Hospital Medicine·Janet FrickerJanet Fricker
Jun 1, 2018·Expert Review of Anti-infective Therapy·Delia GolettiFabrizio Cantini
Nov 6, 2018·The Journal of Rheumatology·Rianne E van BentumIrene E van der Horst-Bruinsma
Dec 14, 2019·Nature Reviews. Rheumatology·Kathryn M KingsmorePeter E Lipsky
Jun 27, 2018·Therapeutic Advances in Musculoskeletal Disease·Fabian Proft, Denis Poddubnyy
Jul 14, 2018·Zeitschrift für Rheumatologie·D SimonA J Hueber
May 10, 2020·Annals of the Rheumatic Diseases·Robert Bm LandewéLianne Gensler
Mar 17, 2019·Rheumatology International·Eleftherios PelechasAlexandros A Drosos
Jan 18, 2018·Expert Review of Clinical Immunology·Fabio Massimo PerrottaEnnio Lubrano
Jul 2, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Mark C HwangJohn Reveille
Mar 17, 2020·Advances in Rheumatology·Gustavo Gomes ResendePercival Degrava Sampaio-Barros
Jul 10, 2019·Reumatología clinica·Greta Reyes-CorderoRuben Burgos-Vargas
Oct 1, 2019·Rheumatic Diseases Clinics of North America·Elena Nikiphorou, Xenofon Baraliakos
Dec 22, 2020·Therapeutic Advances in Musculoskeletal Disease·Katharina MeierKamran Ghoreschi
Jul 23, 2021·Therapeutic Advances in Musculoskeletal Disease·Elsa How Shing KoyYves-Marie Pers
Jul 1, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·R B WarrenA Blauvelt
Sep 19, 2020·Current Rheumatology Reviews·Ioanna G SaougouAlexandros A Drosos
Nov 30, 2021·Expert Opinion on Investigational Drugs·Leticia Garcia-Montoya, Paul Emery
Jan 5, 2021·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Minh-Duc NgoNicolas Richard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.